skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Update on Systemic Prostate Cancer Therapies: Management of Metastatic Castration-resistant Prostate Cancer in the Era of Precision Oncology
Update on Systemic Prostate Cancer Therapies: Management of Metastatic Castration-resistant Prostate Cancer in the Era of Precision Oncology
Material Type:
Artigo 		Adicionar ao Meu Espaço

Update on Systemic Prostate Cancer Therapies: Management of Metastatic Castration-resistant Prostate Cancer in the Era of Precision Oncology

Nuhn, Philipp ; De Bono, Johann S. ; Fizazi, Karim ; Freedland, Stephen J. ; Grilli, Maurizio ; Kantoff, Philip W. ; Sonpavde, Guru ; Sternberg, Cora N. ; Yegnasubramanian, Srinivasan ; Antonarakis, Emmanuel S.

European urology, 2019-01, Vol.75 (1), p.88-99 [Periódico revisado por pares]

Switzerland: Elsevier B.V

Texto completo disponível

Citações Citado por
2
Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer
Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer

Smith, Matthew R ; Hussain, Maha ; Saad, Fred ; Fizazi, Karim ; Sternberg, Cora N ; Crawford, E. David ; Kopyltsov, Evgeny ; Park, Chandler H ; Alekseev, Boris ; Montesa-Pino, Álvaro ; Ye, Dingwei ; Parnis, Francis ; Cruz, Felipe ; Tammela, Teuvo L.J ; Suzuki, Hiroyoshi ; Utriainen, Tapio ; Fu, Cheng ; Uemura, Motohide ; Méndez-Vidal, María J ; Maughan, Benjamin L ; Joensuu, Heikki ; Thiele, Silke ; Li, Rui ; Kuss, Iris ; Tombal, Bertrand

The New England journal of medicine, 2022-03, Vol.386 (12), p.1132-1142 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
3
Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer
Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer

de Wit, Ronald ; de Bono, Johann ; Sternberg, Cora N ; Fizazi, Karim ; Tombal, Bertrand ; Wülfing, Christian ; Kramer, Gero ; Eymard, Jean-Christophe ; Bamias, Aristotelis ; Carles, Joan ; Iacovelli, Roberto ; Melichar, Bohuslav ; Sverrisdóttir, Ásgerður ; Theodore, Christine ; Feyerabend, Susan ; Helissey, Carole ; Ozatilgan, Ayse ; Geffriaud-Ricouard, Christine ; Castellano, Daniel

The New England journal of medicine, 2019-12, Vol.381 (26), p.2506-2518 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
4
Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer
Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer

Sternberg, Cora N ; Fizazi, Karim ; Saad, Fred ; Shore, Neal D ; De Giorgi, Ugo ; Penson, David F ; Ferreira, Ubirajara ; Efstathiou, Eleni ; Madziarska, Katarzyna ; Kolinsky, Michael P ; Cubero, Daniel I. G ; Noerby, Bettina ; Zohren, Fabian ; Lin, Xun ; Modelska, Katharina ; Sugg, Jennifer ; Steinberg, Joyce ; Hussain, Maha

The New England journal of medicine, 2020-06, Vol.382 (23), p.2197-2206 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
5
Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial
Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial

Choueiri, Toni K, Dr ; Escudier, Bernard, MD ; Powles, Thomas, Prof ; Tannir, Nizar M, Prof ; Mainwaring, Paul N, MD ; Rini, Brian I, Prof ; Hammers, Hans J, MD ; Donskov, Frede, MD ; Roth, Bruce J, Prof ; Peltola, Katriina, MD ; Lee, Jae Lyun, Prof ; Heng, Daniel Y C, MD ; Schmidinger, Manuela, Prof ; Agarwal, Neeraj, MD ; Sternberg, Cora N, Prof ; McDermott, David F, MD ; Aftab, Dana T, PhD ; Hessel, Colin, MS ; Scheffold, Christian, MD ; Schwab, Gisela, MD ; Hutson, Thomas E, Prof ; Pal, Sumanta, MD ; Motzer, Robert J, Prof

The lancet oncology, 2016-07, Vol.17 (7), p.917-927 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
6
Avelumab maintenance in advanced urothelial carcinoma: biomarker analysis of the phase 3 JAVELIN Bladder 100 trial
Avelumab maintenance in advanced urothelial carcinoma: biomarker analysis of the phase 3 JAVELIN Bladder 100 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Avelumab maintenance in advanced urothelial carcinoma: biomarker analysis of the phase 3 JAVELIN Bladder 100 trial

Powles, Thomas ; Sridhar, Srikala S ; Loriot, Yohann ; Bellmunt, Joaquim ; Mu, Xinmeng Jasmine ; Ching, Keith A ; Pu, Jie ; Sternberg, Cora N ; Petrylak, Daniel P ; Tambaro, Rosa ; Dourthe, Louis M ; Alvarez-Fernandez, Carlos ; Aarts, Maureen ; di Pietro, Alessandra ; Grivas, Petros ; Davis, Craig B

Nature medicine, 2021-12, Vol.27 (12), p.2200-2211 [Periódico revisado por pares]

United States: Nature Publishing Group

Texto completo disponível

Citações Citado por
7
Primary Results from SAUL, a Multinational Single-arm Safety Study of Atezolizumab Therapy for Locally Advanced or Metastatic Urothelial or Nonurothelial Carcinoma of the Urinary Tract
Primary Results from SAUL, a Multinational Single-arm Safety Study of Atezolizumab Therapy for Locally Advanced or Metastatic Urothelial or Nonurothelial Carcinoma of the Urinary Tract
Material Type:
Artigo 		Adicionar ao Meu Espaço

Primary Results from SAUL, a Multinational Single-arm Safety Study of Atezolizumab Therapy for Locally Advanced or Metastatic Urothelial or Nonurothelial Carcinoma of the Urinary Tract

Sternberg, Cora N. ; Loriot, Yohann ; James, Nicholas ; Choy, Ernest ; Castellano, Daniel ; Lopez-Rios, Fernando ; Banna, Giuseppe L. ; De Giorgi, Ugo ; Masini, Cristina ; Bamias, Aristotelis ; Garcia del Muro, Xavier ; Duran, Ignacio ; Powles, Thomas ; Gamulin, Marija ; Zengerling, Friedemann ; Geczi, Lajos ; Gedye, Craig ; de Ducla, Sabine ; Fear, Simon ; Merseburger, Axel S.

European urology, 2019-07, Vol.76 (1), p.73-81 [Periódico revisado por pares]

Switzerland: Elsevier B.V

Texto completo disponível

Citações Citado por
8
Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial
Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial

Sternberg, Cora N ; Davis, Ian D ; Mardiak, Jozef ; Szczylik, Cezary ; Lee, Eunsik ; Wagstaff, John ; Barrios, Carlos H ; Salman, Pamela ; Gladkov, Oleg A ; Kavina, Alexander ; Zarbá, Juan J ; Chen, Mei ; McCann, Lauren ; Pandite, Lini ; Roychowdhury, Debasish F ; Hawkins, Robert E

Journal of clinical oncology, 2010-02, Vol.28 (6), p.1061-1068 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
9
Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study
Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study

Fizazi, Karim, Prof Dr ; Scher, Howard I, Prof ; Molina, Arturo, MD ; Logothetis, Christopher J, Prof ; Chi, Kim N, MD ; Jones, Robert J, PhD ; Staffurth, John N, MD ; North, Scott, MD ; Vogelzang, Nicholas J, MD ; Saad, Fred, Prof ; Mainwaring, Paul, MD ; Harland, Stephen, MD ; Goodman, Oscar B, MD ; Sternberg, Cora N, MD ; Li, Jin Hui, PhD ; Kheoh, Thian, PhD ; Haqq, Christopher M, MD ; de Bono, Johann S, Prof

The lancet oncology, 2012-10, Vol.13 (10), p.983-992 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
10
Tivozanib Versus Sorafenib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma: Results From a Phase III Trial
Tivozanib Versus Sorafenib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma: Results From a Phase III Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Tivozanib Versus Sorafenib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma: Results From a Phase III Trial

MOTZER, Robert J ; NOSOV, Dmitry ; KOGAN, Mikhail ; ALEKSEEV, Boris Y ; STERNBERG, Cora N ; SZCZYLIK, Cezary ; CELLA, David ; IVANESCU, Cristina ; KRIVOSHIK, Andrew ; STRAHS, Andrew ; ESTEVES, Brooke ; BERKENBLIT, Anna ; EISEN, Timothy ; HUTSON, Thomas E ; BONDARENKO, Igor ; LESOVOY, Vladimir ; LIPATOV, Oleg ; TOMCZAK, Piotr ; LYULKO, Oleksiy ; ALYASOVA, Anna ; HARZA, Mihai

Journal of clinical oncology, 2013-10, Vol.31 (30), p.3791-3799 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (563)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (573)
  2. Book Chapters  (40)
  3. Resenhas  (4)
  4. Conjunto de Dados  (2)
  5. Livros  (2)
  6. Reports  (2)
  7. Outros  (2)
  8. Anais de Congresso  (2)
  9. Recursos Textuais  (1)
  10. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1989  (16)
  2. 1989Até1998  (19)
  3. 1999Até2007  (65)
  4. 2008Até2016  (241)
  5. Após 2016  (288)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (626)
  2. Japonês  (55)
  3. Russo  (3)
  4. Norueguês  (1)
  5. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.